puritan

Covidien has received European Economic Area (EEA) CE Mark approval for its Puritan Bennett 980 ventilator, designed to deliver advanced breath technology with enhanced patient comfort and clinician ease-of-use.

The Puritan Bennett 980 ventilator helps clinicians set the ventilator to adapt to their patients’ unique needs and provide the appropriate level of support throughout the breath.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It is designed for patients ranging from neonatal to adult.

The next-generation acute ventilation platform offers a range of software capabilities, including proportional assist ventilation plus (PAV+) technology, licensed from University of Manitoba in Canada that provides smarter pumping to optimally synchronise with every patient and leak sync software.

PAV+ technology has been shown to help reduce asynchrony, which studies have shown may ease days on mechanical ventilation.

"PAV+ technology has been shown to help reduce asynchrony, which studies have shown may ease days on mechanical ventilation."

With its range of software capabilities, the new ventilator system helps clinicians get patients off mechanical ventilation as early as possible.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Covidien Europe president Cristiano Franzi said: "Building on Covidien’s strong legacy of innovation, the Puritan Bennett 980 ventilator will provide clinicians with a simple, safe and smart way to care for patients."

On February 26, the company obtained US Food and Drug Administration (FDA) 510(k) clearance for the Puritan Bennett 980 ventilator.

The system was also approved for commercial distribution in Japan and Canada and will be available for sale in those countries, as well as the EEA in the coming months.

According to GlobalData estimates, the Europe ventilators market was valued at $169m in 2012 and is expected to grow at a CAGR of 3.4% to reach $214m by 2019.


Image: Puritan Bennett 980 ventilator gets CE Mark clearance. Photo: courtesy of Covidien/Business Wire.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact